Mind Medicine (MindMed) Inc. (MNMD)
NASDAQ: MNMD · IEX Real-Time Price · USD
8.05
+0.12 (1.51%)
Jul 22, 2024, 10:11 AM EDT - Market open
Mind Medicine (MindMed) Employees
Mind Medicine (MindMed) had 57 employees as of December 31, 2023. The number of employees increased by 9 or 18.75% compared to the previous year.
Employees
57
Change (1Y)
9
Growth (1Y)
18.75%
Revenue / Employee
n/a
Profits / Employee
-$2,198,544
Market Cap
570.35M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 57 | 9 | 18.75% |
| Dec 31, 2022 | 48 | 7 | 17.07% |
| Dec 31, 2021 | 41 | 19 | 86.36% |
| Dec 31, 2020 | 22 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Canopy Growth | 1,029 |
| Castle Biosciences | 610 |
| Quanterix | 441 |
| National Research | 435 |
| Alector | 244 |
| iTeos Therapeutics | 157 |
| OmniAb | 106 |
| Terns Pharmaceuticals | 66 |
MNMD News
- 5 days ago - MindMed Announces Issuance of New Patent for MM120 Orally Disintegrating Tablet (ODT) - Business Wire
- 24 days ago - MindMed to be Included in Russell 2000® and Russell 3000® Indexes - Business Wire
- 4 weeks ago - MindMed to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference - Business Wire
- 4 weeks ago - MindMed Announces Constructive End-of-Phase 2 Meeting with U.S. FDA for MM120 in Generalized Anxiety Disorder (GAD) - Business Wire
- 7 weeks ago - MindMed to Participate in June Conferences - Business Wire
- 2 months ago - MindMed to Participate at May Investor Conferences - Business Wire
- 2 months ago - New Studies Presented at the International Society for Health Economics and Outcomes Research Meeting (ISPOR 24) Show Growing Burden and Impact of Generalized Anxiety Disorder (GAD) in the US - Business Wire
- 2 months ago - MindMed Reports First Quarter 2024 Financial Results and Business Updates - Business Wire